Ignite Creation Date:
2024-05-06 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 12:55 PM
Study NCT ID:
NCT03687567
Status:
COMPLETED
Last Update Posted:
2022-01-11
First Post:
2018-09-26
Brief Title:
A Retrospective Study on the Effect of HBA or HBB Genetic Defects on Early Embryonic Development
Sponsor:
Reproductive Genetic Hospital of CITIC-Xiangya
Organization:
Reproductive Genetic Hospital of CITIC-Xiangya
Study Overview
Official Title:
A Retrospective Study on the Effect of HBA or HBB Genetic Defects on Early Embryonic Development
Status:
COMPLETED
Status Verified Date:
2021-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Thalassemia is an anemia or pathological state caused by compounding absently or inadequately of one or more globin chains of hemoglobin due to the defects of the globin geneand the carrying rate is high in southern China Although there are many studies of Thalassemia the relationship between the globin gene defects and the early embryo development has not been reported
This study intends to carry out a retrospective analysis on the embryonic development of the patients with thalassemia assisted by PGD from January 1 2011 to now in our hospital to explore whether the HBA or HBB gene defects have a certain influence on the early embryo development so as to accumulate certain data for reproductive health research
This study intends to carry out a retrospective analysis on the embryonic development of the patients with thalassemia assisted by PGD from January 1 2011 to now in our hospital to explore whether the HBA or HBB gene defects have a certain influence on the early embryo development so as to accumulate certain data for reproductive health research
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None